Ron Bates currently serves as the SVP of Technical Operations at Anthos Therapeutics, focusing on CMC activities and supply chain for biopharmaceutical assets. Previously, Ron was the VP of CMC Process Development and Technical Operations at Immunovant, overseeing the development and manufacturing of anti-FcRN monoclonal antibodies. Ron's career includes roles such as Director of Manufacturing Sciences and Technology at Bristol-Myers Squibb, Director of Process Development at Allergan, and Senior Manager of Process Development at Bristol-Myers Squibb. The early career included a position as Senior Scientist at Pfizer. Ron holds a Ph.D. in Biochemical Engineering from the University of Maryland Baltimore County and a BS in Chemical Engineering from Rensselaer Polytechnic Institute.